Biblio

Found 11 results
Filters: Keyword is Cognition  [Clear All Filters]
2021
Liu X, Li X, Xia B, Jin X, Zou Q, Zeng Z, Zhao W, Yan S, Li L, Yuan S et al..  2021.  High-fiber diet mitigates maternal obesity-induced cognitive and social dysfunction in the offspring via gut-brain axis.. Cell Metab. 33(5):923-938.e6.
2020
Liu Z, Dai X, Zhang H, Shi R, Hui Y, Jin X, Zhang W, Wang L, Wang Q, Wang D et al..  2020.  Gut microbiota mediates intermittent-fasting alleviation of diabetes-induced cognitive impairment.. Nat Commun. 11(1):855.
Wang Y, Hernandez G, Mack WJ, Schneider LS, Yin F, Brinton RD.  2020.  Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy.. Menopause. 27(1):57-65.
2018
Pandit V, Khan M, Zakaria ERasheid, Largent-Milnes TM, Hamidi M, O'Keeffe T, Vanderah TW, Joseph B.  2018.  Continuous remote ischemic conditioning attenuates cognitive and motor deficits from moderate traumatic brain injury.. J Trauma Acute Care Surg. 85(1):48-53.
2016
Karim R, Dang H, Henderson VW, Hodis HN, St John J, Brinton RD, Mack WJ.  2016.  Effect of Reproductive History and Exogenous Hormone Use on Cognitive Function in Mid- and Late Life.. J Am Geriatr Soc. 64(12):2448-2456.
Rettberg JR, Dang H, Hodis HN, Henderson VW, St John JA, Mack WJ, Brinton RDiaz.  2016.  Identifying postmenopausal women at risk for cognitive decline within a healthy cohort using a panel of clinical metabolic indicators: potential for detecting an at-Alzheimer's risk metabolic phenotype.. Neurobiol Aging. 40:155-63.
2015
Espeland MA, Brinton RDiaz, Hugenschmidt C, Manson JAE, Craft S, Yaffe K, Weitlauf J, Vaughan L, Johnson KC, Padula CB et al..  2015.  Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women.. Diabetes Care. 38(12):2316-24.
Brinton RD, Yao J, Yin F, Mack WJ, Cadenas E.  2015.  Perimenopause as a neurological transition state.. Nat Rev Endocrinol. 11(7):393-405.
2009
Brinton RDiaz.  2009.  Estrogen-induced plasticity from cells to circuits: predictions for cognitive function.. Trends Pharmacol Sci. 30(4):212-22.
2008
Foy MR, Baudry M, Brinton RDiaz, Thompson RF.  2008.  Estrogen and hippocampal plasticity in rodent models.. J Alzheimers Dis. 15(4):589-603.
2005
D Sparks L, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Petanceska S, Browne P, Wassar D, Johnson-Traver S, Lochhead J et al..  2005.  Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD.. Curr Alzheimer Res. 2(3):343-53.